Skip to search formSkip to main contentSkip to account menu

Bonefos

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
496 Background: We evaluated the role of bisphosphonates in conjunction with sorafenib in improving progression-free survival… 
2013
2013
Experimental autoimmune neuritis (EAN) serves as an animal model for human Gullain–Barre syndrome (GBS), an autoimmune disease… 
2008
2008
Objective: To evaluate the clinical efficacy and safety of Ibandronate and Bonefos for non-small cell lung cancer (NSCLC) with… 
2006
2006
TRANSPLANTATION (KT). I.Rekina~ M.Mirovski, S.Rodionova*, N.Tomilina, Inst. of Transplantology and Artificial Organs, Inst. of… 
Review
2004
Review
2004
Bisphosphonate therapy has become a standard of care for patients with malignant bone disease. In addition, preclinical and… 
2004
2004
528 Background: The bisphosphonate clodronate (Bonefos) may reduce the incidence of bone metastases by inhibiting tumor-induced… 
2002
2002
BACKGROUND To evaluate the effect of ⁸⁹SrCl₂ and/or Bonefos in the treatment of bone metastasis from pulmonary carcinoma… 
2000
2000
AIM To evaluate the effect of 153 Sm EDTMP or/and bonefos in the treatment of 60 cases of metastatic bone cancer. METHODS All… 
1998
1998
The problem of osteoporosis is world-wide in people above 50 years of age. As this period is also a risk period for the…